letter . 2017 Apr 18;24(6):L35–L38. doi: 10.1530/ERC-17-0104
This work is licensed under a Table 1.
Clinicopathological data and PD-L1 expression in malignant cells and immune cells.
| Patient n° | Sex/age, years | Type of initial thyroidectomy | Size, cm | pT | pN | PD-L1 expression, % (malignant cells) | PD-L1 expression, % (immune cells) | Status and length of follow-up (years) |
|---|---|---|---|---|---|---|---|---|
| 1 | M/47 | Total | 3.2 | 3 | 1b | <1 | 0 | Alive (1,0) |
| 2 | F/58 | Total | 4 | 2 | 0 | 0 | 0 | Alive (1,4) |
| 3 | M/47 | Hemi | 2.1 | 2 | 0 | <1 | 0 | Alive (6,5) |
| 4 | F/45 | Total | 6.2 | 3 | 1a | 1 | 0 | Dead (0,5) |
| 5 | M/61 | Total | 4.5 | 3 | 1b | <1 | 0 | Dead (6,7) |
| 5 bis* | 1.9 | <1 | 0 | |||||
| 6 | M/71 | Total | 1.5 | 1b | 1b | 1 | 0 | Dead (1,6) |
| 7 | F/40 | Total | 3 | 3 | 1 | 0 | 0 | Lost to follow up |
| 8 | F/64 | Total | 0.6 | 1a | 0 | 0 | 0 | Alive (6,5) |
| 9 | F/34 | Total | 2.1 | 3 | 1 | 0 | 0 | Dead (9,1) |
| 10 | F/52 | Hemi | 0.8 | 1a | x | 5 | 0 | Alive (11,5) |
| 11 | F/69 | Total | 3.5 | 4a | 1b | 1 | 1 | Alive (6,5) |
| 12 | F/21 | Total | 4.8 | 3 | x | <1 | 2 | Dead (5,10) |
| 13 | F/45 | Hemi | 8 | 3 | x | 0 | 0 | Lost to follow up |
| 14 | F/37 | Total | 2.9 | 2 | 1b | 0 | 0 | Alive with MTS (8,6) |
| 15 | F/58 | Total | 1.3 | 1b | 0 | 0 | 0 | Alive (0,5) |
| 16 | M/32 | Hemi | 1.5 | 1b | x | 0 | 0 | Dead (13,7) |
*
Lymph node metastasis of patient 5.